[en] Human respiratory syncytial virus (RSV) is a pneumovirus that causes severe infections in infants worldwide. Despite intensive research, safe and effective vaccines against RSV have remained elusive. The main reason is that RSV infection of children previously immunized with formalin-inactivated-RSV vaccines has been associated with exacerbated pathology, a phenomenon called RSV vaccine-enhanced respiratory disease. In parallel, despite the high RSV prevalence, only a minor proportion of children develop severe diseases. Interestingly, variation in the immune responses against RSV or following RSV vaccination could be linked with differences of exposure to microbes during childhood. Gammaherpesviruses (γHVs), such as the Epstein–Barr virus, are persistent viruses that deeply influence the immune system of their host and could therefore affect the development of pneumovirus-induced immunopathologies for the long term. Here, we showed that a previous ɣHV infection protects against both pneumovirus vaccine-enhanced disease and pneumovirus primary infection and that CD8 T cells are essential for this protection. These observations shed a new light on the understanding of pneumovirus-induced diseases and open new perspectives for the development of vaccine strategies.
Immunology & infectious disease
Author, co-author :
Dourcy, Mickael ; Université de Liège - ULiège > Département de morphologie et pathologie (DMP) > Anatomie des animaux domestiques
Maquet, Céline ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire
Dams, Lorène ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Département des maladies infectieuses et parasitaires (DMI)
Gilliaux, Gautier ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Santé et pathologies de la faune sauvage
Hall, C. B. et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588–598 (2009).
Shaw, C. A. et al. The path to an RSV vaccine. Curr. Opin. Virol. 3, 332–342 (2013).
Kim, H. W. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422–434 (1969).
Castilow, E. M., Olson, M. R. & Varga, S. M. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunol. Res. 39, 225–239 (2007).
Ruckwardt, T. J., Morabito, K. M. & Graham, B. S. Determinants of early life immune responses to RSV infection. Curr. Opin. Virol. 16, 151–157 (2016).
Fonseca, W., Lukacs, N. W. & Ptaschinski, C. Factors affecting the immunity to respiratory syncytial virus: from epigenetics to microbiome. Front. Immunol. 9, 226 (2018).
Cadwell, K. The virome in host health and disease. Immunity 42, 805–813 (2015).
Duerkop, B. A. & Hooper, L.V. Resident viruses and their interactions with the immune system. Nat. Immunol. 14, 654–659 (2013).
Virgin, H. W. The virome in mammalian physiology and disease. Cell 157, 142–150 (2014).
Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47 (2015).
Machiels, B. et al. A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nat. Immunol. 18, 1310–1320 (2017).
Dowd, J. B., Palermo, T., Brite, J., McDade, T. W. & Aiello, A. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS ONE 8, e64921 (2013).
Sacco, R. E., Durbin, R. K. & Durbin, J. E. Animal models of respiratory syncytial virus infection and disease. Curr. Opin. Virol. 13, 117–122 (2015).
Rosenberg, H. F. & Domachowske, J. B. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol. Lett. 118, 6–12 (2008).
Anh, D. B. T., Faisca, P. & Desmecht, D. J.-M. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L426–L435 (2006).
Percopo, C. M. et al. Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice. J. Immunol. 183, 604–612 (2009).
Anderson, V. E., Nguyen, Y. & Weinberg, J. B. Effects of allergic airway disease on mouse adenovirus type 1 respiratory infection. Virology 391, 25–32 (2009).
Saito, F. et al. MHV68 latency modulates the host immune response to influenza A virus. Inflammation 36, 1295–1303 (2013).
HAQUE, A. et al. Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin. Exp. Immunol. 138, 396–404 (2004).
Wills-Karp, M., Santeliz, J. & Karp, C. L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1, 69–75 (2001).
Strachan, D. P. Hay fever, hygiene, and household size. BMJ 299, 1259–1260 (1989).
Haspeslagh, E., Heyndrickx, I., Hammad, H. & Lambrecht, B. N. The hygiene hypothesis: immunological mechanisms of airway tolerance. Curr. Opin. Immunol. 54, 102–108 (2018).
Barton, E., Mandal, P. & Speck, S. H. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29, 351–397 (2011).
Mesnil, C. et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J. Clin. Investig. 126, 3279–3295 (2016).
Hegazy, A. N. et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3+T-bet+ cell subset with combined Th2 and Th1 cell functions. Immunity 32, 116–128 (2010).
Kim, B.-S. et al. Conversion of Th2 memory cells into Foxp3 + regulatory T cells suppressing Th2-mediated allergic asthma. 10.1073/pnas.0911756107.
Dyer, K. D., Percopo, C. M., Fischer, E. R., Gabryszewski, S. J. & Rosenberg, H. F. Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood 114, 2649–2656 (2009).
Percopo, C. M. et al. Critical adverse impact of IL-6 in acute pneumovirus infection. J. Immunol. 202, 871–882 (2019).
Essers, M. A. et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).
Soudja, S. M., Ruiz, A. L., Marie, J. C. & Lauvau, G. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37, 549–562 (2012).
Askenase, M. H. et al. Bone-Marrow-resident NK cells prime monocytes for regulatory function during Infection. Immunity 42, 1130–1142 (2015).
Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697–4704 (2001).
Jacoby, M. A., Virgin, H. W.4th, & Speck, S. H. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 76, 1790–1801 (2002).
Marshall, D. R. et al. Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression. Proc. Natl Acad. Sci. USA 102, 6074–6079 (2005).
Kohlmeier, J. E. et al. Interferons regulate cytolytic activity of memory CD8+ T cells in the lung airways during respiratory virus challenge. Immunity 33, 96–105 (2010).
Brodin, P. & Davis, M. M. Human immune system variation. Nat. Rev. Immunol. 17, 21–29 (2017).
Hijano, D. R. et al. Role of Type I interferon (IFN) in the respiratory syncytial virus (RSV) immune response and disease severity. Front. Immunol. 10, 566 (2019).
Graham, B. S. Vaccine development for respiratory syncytial virus. Curr. Opin. Virol. 23, 107–112 (2017).
Walzl, G., Tafuro, S., Moss, P., Openshaw, P. J. & Hussell, T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. Med. 192, 1317–1326 (2000).
Fonseca, W. et al. Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation. Mucosal Immunol. 10, 1569–1580 (2017).
Selin, L. K., Varga, S. M., Wong, I. C. & Welsh, R. M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188, 1705–1715 (1998).
Welsh, R. M. & Selin, L. K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2, 417–426 (2002).
Graham, B. S., Bunton, L. A., Wright, P. F. & Karzon, D. T. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88, 1026–1033 (1991).
Graham, B. S., Rutigliano, J. A. & Johnson, T. R. Respiratory syncytial virus immunobiology and pathogenesis. Virology 297, 1–7 (2002).
Schmidt, M. E. & Varga, S. M. Cytokines and CD8 T cell immunity during respiratory syncytial virus infection. Cytokine (2018). 10.1016/j.cyto.2018.07.012. DOI: 10.1016/j.cyto.2018.07.012
Welliver, T. P. et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195, 1126–1136 (2007).
Openshaw, P. J. M. & Tregoning, J. S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18, 541–555 (2005).
Schmidt, M. E. et al. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. PLoS Pathog. 14, 1–24 (2018).
Kim, C. K. et al. Bronchoalveolar lavage cellular composition in acute asthma and acute bronchiolitis. J. Pediatr. 137, 517–522 (2000).
Chu, T. et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep. 3, 701–708 (2013).
Kim, J. et al. Innate-like cytotoxic function of bystander-activated CD8 + T cells is associated with liver injury in acute hepatitis A. Immunity 48, 161–173 (2018). e5.
Schenkel, J. M. et al. Resident memory CD8 t cells trigger protective innate and adaptive immune responses. Science 346, 98–101 (2014).
Nakamura, Y. et al. Helper function of memory CD8+ T cells: heterologous CD8 + T cells support the induction of therapeutic cancer immunity. Cancer Res. 67, 10012–10018 (2007).
Molloy, M. J., Zhang, W. & Usherwood, E. J. Suppressive CD8 + T cells arise in the absence of CD4 help and compromise control of persistent virus. J. Immunol. 186, 6218–6226 (2011).
Yao, Y. et al. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to article induction of autonomous memory alveolar macrophages requires T cell help. Cell 1–17 (2018). 10.1016/j.cell.2018.09.042.
Dyer, K. D. et al. Priming of the respiratory tract with immunobiotic Lactobacillus plantarum limits infection of alveolar macrophages with recombinant pneumonia virus of mice (rK2-PVM). J. Virol. 90, 979–991 (2016).
Rigaux, P., Killoran, K. E., Qiu, Z. & Rosenberg, H. F. Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection. Virology 422, 338–345 (2012).
Latif, M. B. et al. Deletion of murid herpesvirus 4 ORF63 affects the trafficking of incoming capsids toward the nucleus. J. Virol. 90, 2455–2472 (2016).